Hermawan, A., & Putri, H. (2022). Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy. Springer.
Chicago Style CitationHermawan, Adam, and Herwandhani Putri. Bioinformatics Analysis Reveals the Potential Target of Rosiglitazone As an Antiangiogenic Agent for Breast Cancer Therapy. Springer, 2022.
MLA引文Hermawan, Adam, and Herwandhani Putri. Bioinformatics Analysis Reveals the Potential Target of Rosiglitazone As an Antiangiogenic Agent for Breast Cancer Therapy. Springer, 2022.
警告：這些引文格式不一定是100％准確.